Understanding How Vaccines Boost Your Immune System

Vaccines train the immune system to recognize and fight specific pathogens without causing disease. They exploit the adaptive immune system's capacity for specificity and memory.

Vaccine Components

• Antigen: The target—weakened/killed pathogen, subunit protein, polysaccharide, mRNA/DNA encoding antigen, viral vector.
• Adjuvant: Enhances innate immune activation (aluminum salts, AS01, CpG, squalene emulsion) → stronger adaptive response.
• Stabilizers, preservatives, buffers: Ensure potency, sterility, pH.

Step-by-Step Immune Activation

1. Antigen uptake & presentation: APCs (dendritic cells, macrophages) engulf vaccine antigens at injection site → migrate to draining lymph node.
2. T-cell priming: DCs present peptide-MHC II to naïve CD4+ T cells → activation, proliferation, differentiation (Th1, Th2, Tfh, Treg).
3. B-cell activation: Naïve B cells bind native antigen via BCR → internalize, present to Tfh cells → receive CD40L + cytokines (IL-4, IL-21) → germinal center formation.
4. Germinal center reaction: Somatic hypermutation + affinity maturation → high-affinity B cells.
5. Differentiation:
   • Plasma cells (short-lived → early antibodies; long-lived → bone marrow residence → decades of antibody secretion).
   • Memory B cells (rapid response on re-exposure).
6. CD8+ T-cell priming (cross-presentation): For intracellular pathogens → CTL memory.
7. Effector phase: Antibodies neutralize, opsonize, activate complement; T cells kill infected cells, orchestrate inflammation.
8. Contraction & memory: 90-95% of effectors die; memory pools persist.

Vaccine Types & Immune Profiles

Platform	Examples	Key Immune Features
Live attenuated	MMR, Varicella, Rotavirus, LAIV	Replicates mildly → strong CD8+ T cell, mucosal IgA, durable memory
Inactivated	IPV, Hepatitis A, Rabies, IIV	No replication → mainly humoral (Th2); needs adjuvant, boosters
Subunit/Protein	Hepatitis B, HPV, acellular Pertussis, Novavax	Pure antigen + adjuvant → focused antibody, Th bias by adjuvant
mRNA	Pfizer/Moderna COVID-19	Endogenous antigen expression → robust Th1, CD8+, neutralizing Ab
Viral vector	J&J, AstraZeneca, Sputnik, Ebola	Transduces cells → strong CD8+, Th1; anti-vector immunity limits boosting
Conjugate	Hib, PCV, MenACWY	Polysaccharide + carrier protein → T-dependent response in infants

Herd Immunity

High population coverage reduces transmission, protecting those who cannot be vaccinated (infants, immunocompromised). Threshold = 1 - 1/R₀.

Vaccines are among the most cost-effective health interventions. They mimic infection's educational signal without its destructive pathology.